These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 12242540

  • 1. Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration.
    Strijks E, van't Hof M, Sweep F, Lenders JW, Oyen WJ, Horstink MW.
    J Neurol; 2002 Sep; 249(9):1206-10. PubMed ID: 12242540
    [Abstract] [Full Text] [Related]

  • 2. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT, Pivonello R, Salvatore E, Faggiano A, Barone P, De Michele G, Lombardi G, Colao A, Filla A.
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
    [Abstract] [Full Text] [Related]

  • 3. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography.
    Lee EA, Kim BJ, Lee WY.
    Mov Disord; 2002 Nov; 17(6):1242-7. PubMed ID: 12465063
    [Abstract] [Full Text] [Related]

  • 4. Is clonidine-growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?
    Mathias CJ, Kimber J, Watson L, Muthane U.
    J Neurol; 2002 Apr; 249(4):488-9. PubMed ID: 11967661
    [No Abstract] [Full Text] [Related]

  • 5. The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms.
    Pellecchia MT, Longo K, Manfredi M, Lucetti C, Cossu G, Petrone A, Marconi R, Sensi M, Epifanio A, Eleopra R, Marchese R, Scaravilli T, Morgante L, Abbruzzese G, Bonuccelli U, Donati E, Pivonello R, Colao A, Barone P.
    Mov Disord; 2008 Jan 30; 23(2):190-4. PubMed ID: 18044703
    [Abstract] [Full Text] [Related]

  • 6. Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects.
    Bonnet AM, Pichon J, Vidailhet M, Gouider-Khouja N, Robain G, Perrigot M, Agid Y.
    Mov Disord; 1997 Jul 30; 12(4):509-13. PubMed ID: 9251068
    [Abstract] [Full Text] [Related]

  • 7. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
    Happe S, Tings T, Helmschmied K, Neubert K, Wuttke W, Paulus W, Trenkwalder C.
    Mov Disord; 2004 Dec 30; 19(12):1511-5. PubMed ID: 15390061
    [Abstract] [Full Text] [Related]

  • 8. [Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy].
    Rouco I, Gómez JC, Lezcano E, Aniel-Quiroga MA, Velasco F, Barcena J, Pérez Bas M, Hurtado P, Cruz Lachén M, Zarranz JJ.
    Neurologia; 2006 Apr 30; 21(3):119-23. PubMed ID: 16575624
    [Abstract] [Full Text] [Related]

  • 9. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
    Kimber JR, Watson L, Mathias CJ.
    Lancet; 1997 Jun 28; 349(9069):1877-81. PubMed ID: 9217760
    [Abstract] [Full Text] [Related]

  • 10. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G, Lodi R, Condino F, Tonon C, Fera F, Malucelli E, Manners D, Zappia M, Morgante L, Barone P, Barbiroli B, Quattrone A.
    Brain; 2006 Oct 28; 129(Pt 10):2679-87. PubMed ID: 16815875
    [Abstract] [Full Text] [Related]

  • 11. Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy).
    Stefanova N, Lundblad M, Tison F, Poewe W, Cenci MA, Wenning GK.
    Neurobiol Dis; 2004 Apr 28; 15(3):630-9. PubMed ID: 15056471
    [Abstract] [Full Text] [Related]

  • 12. "Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical study.
    Gouider-Khouja N, Vidailhet M, Bonnet AM, Pichon J, Agid Y.
    Mov Disord; 1995 May 28; 10(3):288-94. PubMed ID: 7651445
    [Abstract] [Full Text] [Related]

  • 13. Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia.
    Pellecchia MT, Salvatore E, Pivonello R, Faggiano A, Barone P, De Michele G, Colao AM, Filla A.
    Neurol Sci; 2001 Feb 28; 22(1):79-80. PubMed ID: 11487211
    [Abstract] [Full Text] [Related]

  • 14. Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?
    Tranchant C, Guiraud-Chaumeil C, Echaniz-Laguna A, Warter JM.
    J Neurol; 2000 Nov 28; 247(11):853-6. PubMed ID: 11151417
    [Abstract] [Full Text] [Related]

  • 15. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
    Nicoletti G, Tonon C, Lodi R, Condino F, Manners D, Malucelli E, Morelli M, Novellino F, Paglionico S, Lanza P, Messina D, Barone P, Morgante L, Zappia M, Barbiroli B, Quattrone A.
    Mov Disord; 2008 Dec 15; 23(16):2370-6. PubMed ID: 18816803
    [Abstract] [Full Text] [Related]

  • 16. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
    Saiki S, Hirose G, Sakai K, Kataoka S, Hori A, Saiki M, Kaito M, Higashi K, Taki S, Kakeshita K, Fujino S, Miaki M.
    J Neurol Sci; 2004 May 15; 220(1-2):105-11. PubMed ID: 15140615
    [Abstract] [Full Text] [Related]

  • 17. Grading of neuropathology in multiple system atrophy: proposal for a novel scale.
    Jellinger KA, Seppi K, Wenning GK.
    Mov Disord; 2005 Aug 15; 20 Suppl 12():S29-36. PubMed ID: 16092088
    [Abstract] [Full Text] [Related]

  • 18. Prospective study of relevance of 123I-MIBG myocardial scintigraphy and clonidine GH test to distinguish Parkinson's disease and multiple system atrophy.
    Alves Do Rego C, Namer IJ, Marcel C, Lefebvre F, Lagha-Boukbiza O, Renaud M, Tranchant C, Anheim M.
    J Neurol; 2018 Sep 15; 265(9):2033-2039. PubMed ID: 29956027
    [Abstract] [Full Text] [Related]

  • 19. Endurance exercise modulates levodopa induced growth hormone release in patients with Parkinson's disease.
    Müller T, Welnic J, Woitalla D, Muhlack S.
    Neurosci Lett; 2007 Jul 11; 422(2):119-22. PubMed ID: 17590511
    [Abstract] [Full Text] [Related]

  • 20. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G, Martinelli P, Manners D, Scaglione C, Tonon C, Cortelli P, Malucelli E, Capellari S, Testa C, Parchi P, Montagna P, Barbiroli B, Lodi R.
    Brain; 2008 Oct 11; 131(Pt 10):2690-700. PubMed ID: 18819991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.